Factors inducing decreased oocyte maturation rate: a retrospective analysis of 20,939 ICSI cycles
- 23 Downloads
Decreased oocyte maturation rate (OMR) is associated with worse clinical outcomes in IVF/ICSI cycles. The clinical features inducing decreased OMR remain unknown. The study is designed to explore the factors influencing the incidence of decreased OMR and its effects on clinical outcomes.
This is a retrospective case–control study analyzing data from 20,939 ICSI cycles in a reproductive center of university affiliated hospital from January 2015 to December 2017. Patients with a decreased OMR (< 30%) were characterized as Group A and those with an OMR ≥ 30% constituted Group B. Candidate factors of decreased OMR and clinical outcomes were compared between the two groups.
There were 1.3% cycles with an OMR < 30% and 22.16% of all oocytes retrieved (12.87 per cycle in average) were immature. Primary infertility, longer duration of infertility, larger BMI, more previous assisted reproductive times, less oocytes retrieved were risk factors for decreased OMR. Compared with long agonist protocol, patients received antagonist protocol for COH had a higher incidence of decreased OMR. The fertilization rate and subsequent embryo development of oocytes in Group A were worse than Group B. Implantation rate and clinical pregnancy rate were both lower in Group A than Group B.
Primary infertility, duration of infertility, BMI, previous assisted reproductive times, number of oocytes retrieved and COH protocol were found to be factors inducing decreased OMR. Patients with decreased OMR had worse clinical outcomes.
KeywordsOocyte maturation ICSI Risk factor Pregnancy
The authors thank the staff of the Reproductive Medicine Center of Peking University Third Hospital for their invaluable help in data collection. This work was supported by National Natural Science of Foundation of China (81170618) and Key Clinical Program of Peking University Third Hospital (BYSY2015002).
CM: project development, manuscript review. YL: data management, data analysis, manuscript writing. PY: data collection, data analysis, manuscript writing. YC: data collection, manuscript editing. JZ: project development. XZ: data analysis.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Lonergan P, Fair T (2016) Maturation of oocytes in vitro. Annu Rev Anim Biosci 4:255–268. https://doi.org/10.1146/annurev-animal-022114-110822 CrossRefPubMedGoogle Scholar
- 4.Sousa M, Cunha M, Silva J, Oliveira E, Pinho MJ, Almeida C, Sa R, da Silva JT, Oliveira C, Barros A (2016) Ultrastructural and cytogenetic analyses of mature human oocyte dysmorphisms with respect to clinical outcomes. J Assist Reprod Genet 33(8):1041–1057. https://doi.org/10.1007/s10815-016-0739-8 CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Halvaei I, Ali Khalili M, Razi MH, Nottola SA (2012) The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles. J Assist Reprod Genet 29(8):803–810. https://doi.org/10.1007/s10815-012-9799-6 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Gulekli B, Olgan S, Aydiner F (2011) In vitro oocyte maturation from unstimulated cycles: does it offer a realistic chance to overcome the problem of repeated oocyte maturation arrest in IVF? Arch Gynecol Obstet 283(Suppl 1):133–134. https://doi.org/10.1007/s00404-010-1826-1 CrossRefPubMedGoogle Scholar
- 12.Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C (2014) Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril 102(2):405–409. https://doi.org/10.1016/j.fertnstert.2014.04.028 CrossRefPubMedGoogle Scholar
- 15.Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Grondahl ML, Westergaard L, Andersen CY (2005) GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod (Oxf, Engl) 20(5):1213–1220. https://doi.org/10.1093/humrep/deh765 CrossRefGoogle Scholar
- 18.Son WY, Chung JT, Chian RC, Herrero B, Demirtas E, Elizur S, Gidoni Y, Sylvestre C, Dean N, Tan SL (2008) A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles. Hum Reprod (Oxf, Engl) 23(9):2010–2016. https://doi.org/10.1093/humrep/den210 CrossRefGoogle Scholar
- 19.Zilberberg E, Haas J, Dar S, Kedem A, Machtinger R, Orvieto R (2015) Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes. Gynecol Endocrinol 31(2):145–147. https://doi.org/10.3109/09513590.2014.978850 CrossRefPubMedGoogle Scholar